Cairo University
Cairo, Giza Governorate, 6890, Egypt
Location status: Recruiting
NCT Number: NCT07143695
Increased days of MV are not without hazards, including barotraumas and ventilator-associated pneumonia. Similarly, premature separation of MV is associated with increased mortality secondary to adverse cardiorespiratory events. Therefore, the time of weaning should be wisely evaluated. There is growing evidence concerning respiratory muscles dysfunction that contributes to difficulty or prolonged liberation from MV.
Interested in participating?
Request Info18 year–65 year
All sexes
Interventional
Not applicable
Cairo, Giza Governorate, 6890, Egypt
Location status: Recruiting
Researchers aim to evaluate the influence of adding parasternal thickening fraction to the standard weaning criteria and its impact on reintubation
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Parasternal intercostal thickening fraction less than 6.5%
Ultrasound assessment only for purpose of blinding
Time frame: Within 72 hours after extubation
need for reintubation
Time frame: within 72 hours post-extubation
failed spontaneous breathing trial or reintubation
Contact information is provided by the study sponsor or research team.
Cairo University
Other
Parasternal Intercostal Muscle Thickening as an Additive Weaning Criterion to Minimize Re-intubation Rate: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07330505
Critical Illness, Critically Ill
Gothenburg, Sweden
View Trial DetailsNCT07249749
Critical Illness, Critically Ill
Villavicencio, Meta Department, Colombia
View Trial DetailsNCT04502511
Critical Illness, Critically Ill
Groningen, Provincie Groningen, Netherlands
View Trial DetailsNCT07222007
Airway Management, Critical Illness
Jacksonville, Florida, United States
View Trial Details